HF
NTLA icon

HRT Financial’s Intellia Therapeutics NTLA Stock Holding History

HRT Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.44M Sell
502,337
-262,553
-34% -$3.34M 0.02% 848
2025
Q4 		$6.88M Buy
+764,890
New +$10.5M 0.03% 625
2025
Q3 		– Sell
-221,328
Closed -$2.08M – 3486
2025
Q2 		$2.08M Buy
221,328
+133,175
+151% +$1.09M 0.01% 907
2025
Q1 		$626K Buy
88,153
+55,758
+172% +$563K ﹤0.01% 1341
2024
Q4 		$377K Buy
+32,395
New +$506K ﹤0.01% 1590
2021
Q4 		– Sell
-8,913
Closed -$1.2M – 3825
2021
Q3 		$1.2M Buy
+8,913
New +$1.35M 0.01% 1115

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return